FTRE (Fortrea Holdings) Debt-to-Asset : 0.41 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FTRE Fortrea Holdings Inc FTRE
64 GF Score
Price $20.34
GF Value $17.05
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Fortrea Holdings Debt-to-Asset?

Fortrea Holdings FTRE +1.60% 64 Debt-to-Asset is 0.41 as of Jun. 2026. GuruFocus rates FTRE with a GF Score™ of 64/100 and a GF Value™ of $17.05 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Fortrea Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was $26 Mil. Fortrea Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was $1,092 Mil. Fortrea Holdings's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2026 was $2,715 Mil. Fortrea Holdings's debt to asset for the quarter that ended in Jun. 2026 was 0.41.

Fortrea Holdings  (NAS:FTRE) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Fortrea Holdings Debt-to-Asset Related Terms

Fortrea Holdings Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Fortrea Holdings's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortrea Holdings Debt-to-Asset Chart

Fortrea Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
Get a 7-Day Free Trial 0.02 0.02 0.39 0.34 0.41

Fortrea Holdings Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.43 0.41 0.42 0.41

FTRE vs DMRA, RXRX, NTLA: Debt-to-Asset Comparison

For the Biotechnology subindustry, Fortrea Holdings's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fortrea Holdings Debt-to-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortrea Holdings's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Fortrea Holdings's Debt-to-Asset falls into.


FTRE
64GF Score
Fortrea Holdings Inc FTRE
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fortrea Holdings Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Fortrea Holdings's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(14 + 1102) / 2715.7
=0.41

Fortrea Holdings's Debt-to-Asset for the quarter that ended in Jun. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(26 + 1091.5) / 2714.9
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.41 mean?
Fortrea Holdings (FTRE) has a Debt-to-Asset of 0.41 as of Jun. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Fortrea Holdings and its competitors.
Is Fortrea Holdings' Debt-to-Asset too high?
Fortrea Holdings' current Debt-to-Asset is 0.41. Overall, Fortrea Holdings has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fortrea Holdings' Debt-to-Asset compare to DMRA and RXRX?
Fortrea Holdings' Debt-to-Asset of 0.41 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Biotechnology company?
A good Debt-to-Asset depends on the Biotechnology industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Fortrea Holdings and its competitors. Fortrea Holdings's current Debt-to-Asset is 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortrea Holdings stock overvalued right now?
Based on GuruFocus' analysis, Fortrea Holdings (FTRE) is currently considered Modestly Overvalued. The stock's GF Value™ is $17.05, compared to a current price of $20.34 — trading 19.3% above its estimated fair value. The current Debt-to-Asset is 0.41. Fortrea Holdings' overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Fortrea Holdings (FTRE), the current Debt-to-Asset is 0.41 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortrea Holdings (FTRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fortrea Holdings stock appears to be overvalued. The current stock price of $20.34 is trading 19.3% above its estimated GF Value™ of $17.05. GuruFocus considers Fortrea Holdings to be Modestly Overvalued.

Key valuation signals for FTRE:

  • Debt-to-Asset: 0.41
  • GF Value™: $17.05 vs. price of $20.34 (19.3% above fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the FTRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortrea Holdings Business Description

Other Exchanges K67:Germany
Address 8 Moore Drive, Durham, NC, USA, 27713
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
64GF Score

Get the complete analysis for FTRE

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.34
Price
$17.05
GF Value